AAPL took a rare hit today. The consensus rating was downgraded, with analyst recommendations shifting toward a more cautious view. The average target price held near $326. Apple's short interest sits at just 0.9% of free float — shorts are not the story here. The downgrade reflects growing concern over valuation at a $4.6 trillion market cap.
Beauty stocks showed more optimism. Estée Lauder received back-to-back target price increases. Jefferies lifted its target to $100 from $88. Canaccord Genuity moved to $90 from $85. Both firms kept Hold ratings, but the direction is clear — sentiment on the struggling cosmetics giant is slowly improving. At a $24 billion market cap, EL trades well below its peak.
Biotech saw a fresh initiation. Canaccord Genuity started coverage on Incyte with a Buy rating and a $152 target. Incyte has a $26 billion market cap and short interest near 6% of free float. The initiation signals confidence ahead of potential pipeline catalysts.
Amphenol and Marvell Technology both saw consensus target prices edge higher. also gained a target increase to $323 from $317.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
